142 related articles for article (PubMed ID: 19889609)
21. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
[TBL] [Abstract][Full Text] [Related]
22. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
[TBL] [Abstract][Full Text] [Related]
23. Adverse impact of regional lymph node involvement in osteosarcoma.
Thampi S; Matthay KK; Goldsby R; DuBois SG
Eur J Cancer; 2013 Nov; 49(16):3471-6. PubMed ID: 23867123
[TBL] [Abstract][Full Text] [Related]
24. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.
Bernthal NM; Federman N; Eilber FR; Nelson SD; Eckardt JJ; Eilber FC; Tap WD
Cancer; 2012 Dec; 118(23):5888-93. PubMed ID: 22648705
[TBL] [Abstract][Full Text] [Related]
25. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup.
Hauben EI; Weeden S; Pringle J; Van Marck EA; Hogendoorn PC
Eur J Cancer; 2002 Jun; 38(9):1218-25. PubMed ID: 12044509
[TBL] [Abstract][Full Text] [Related]
26. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
[TBL] [Abstract][Full Text] [Related]
27. High-grade surface osteosarcoma: a review of 25 cases from the Rizzoli Institute.
Staals EL; Bacchini P; Bertoni F
Cancer; 2008 Apr; 112(7):1592-9. PubMed ID: 18300258
[TBL] [Abstract][Full Text] [Related]
28. Osteosarcoma in patients younger than 12 years old without metastases have similar prognosis as adolescent and young adults.
Eleutério SJ; Senerchia AA; Almeida MT; Da Costa CM; Lustosa D; Calheiros LM; Barreto JH; Brunetto AL; Macedo CR; Petrilli AS
Pediatr Blood Cancer; 2015 Jul; 62(7):1209-13. PubMed ID: 25755160
[TBL] [Abstract][Full Text] [Related]
29. Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.
Ilcisin LA; Ma C; Janeway KA; DuBois SG; Shulman DS
Pediatr Blood Cancer; 2021 Mar; 68(3):e28834. PubMed ID: 33258278
[TBL] [Abstract][Full Text] [Related]
30. Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma.
Tsuda Y; Tsoi K; Parry MC; Stevenson JD; Fujiwara T; Sumathi V; Jeys LM
Bone Joint J; 2020 Jun; 102-B(6):795-803. PubMed ID: 32475245
[TBL] [Abstract][Full Text] [Related]
31. Osteosarcoma in patients older than 65 years.
Longhi A; Errani C; Gonzales-Arabio D; Ferrari C; Mercuri M
J Clin Oncol; 2008 Nov; 26(33):5368-73. PubMed ID: 18809616
[TBL] [Abstract][Full Text] [Related]
32. Conditional survival of pediatric, adolescent, and young adult soft tissue sarcoma and bone tumor patients.
Ou JY; Spraker-Perlman H; Dietz AC; Smits-Seemann RR; Kaul S; Kirchhoff AC
Cancer Epidemiol; 2017 Oct; 50(Pt A):150-157. PubMed ID: 28992567
[TBL] [Abstract][Full Text] [Related]
33. Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon.
Abou Ali B; Salman M; Ghanem KM; Boulos F; Haidar R; Saghieh S; Akel S; Muwakkit SA; El-Solh H; Saab R; Tamim H; Abboud MR
J Glob Oncol; 2019 Apr; 5():1-8. PubMed ID: 30946633
[TBL] [Abstract][Full Text] [Related]
34. Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis.
Tirtei E; Asaftei SD; Manicone R; Cesari M; Paioli A; Rocca M; Ferrari S; Fagioli F
Tumori; 2018 Jun; 104(3):202-206. PubMed ID: 30086698
[TBL] [Abstract][Full Text] [Related]
35. Primary bone sarcomas in patients over 40 years of age: A retrospective study using data from the Bone Tumor Registry of Japan.
Nagano A; Ishimaru D; Nishimoto Y; Akiyama H; Kawai A
J Orthop Sci; 2017 Jul; 22(4):749-754. PubMed ID: 28412026
[TBL] [Abstract][Full Text] [Related]
36. Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy.
Paludo J; Fritchie K; Haddox CL; Rose PS; Arndt CAS; Marks RS; Galanis E; Okuno SH; Robinson SI
Am J Clin Oncol; 2018 Sep; 41(9):832-837. PubMed ID: 28622153
[TBL] [Abstract][Full Text] [Related]
37. Treatment outcome of osteosarcoma after bilateral retinoblastoma: a retrospective study of eight cases.
Lee JA; Choi SY; Kang HJ; Lee JW; Kim H; Kim JH; Sung KW; Shin HY; Ahn HS; Park KD
Br J Ophthalmol; 2014 Oct; 98(10):1355-9. PubMed ID: 24795337
[TBL] [Abstract][Full Text] [Related]
38. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.
Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S
Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936
[TBL] [Abstract][Full Text] [Related]
39. Head and neck osteosarcoma at the University of Washington.
Oda D; Bavisotto LM; Schmidt RA; McNutt M; Bruckner JD; Conrad EU; Weymuller EA
Head Neck; 1997 Sep; 19(6):513-23. PubMed ID: 9278760
[TBL] [Abstract][Full Text] [Related]
40. Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54.
Uribe-Botero G; Russell WO; Sutow WW; Martin RG
Am J Clin Pathol; 1977 May; 67(5):427-35. PubMed ID: 266360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
